Halozyme beruft Jim Daly in Verwaltungsrat

Von Public Technologies20:08 (UTC), 30 September 2026 Aktualisiert

Halozyme beruft James «Jim» Daly in den Verwaltungsrat.
Daly war 2012–2015 Executive Vice President und Chief Commercial Officer bei Incyte.
Zuvor leitete er bei Amgen als Senior Vice President die North America Commercial Operations sowie Global Marketing und Commercial Development.
Früher war er mehr als 16 Jahre bei Glaxo Wellcome/GlaxoSmithKline, zuletzt als Senior Vice President und General Manager des US-Respiratory-Geschäfts.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Halozyme Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA59857) on September 30, 2026, and is solely responsible for the information contained therein.